ClinConnect ClinConnect Logo
Search / Trial NCT05989841

Mitigating PTSD-CUD After Sexual Assault

Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Aug 10, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital therapy designed to help women who have experienced sexual assault and are at risk of developing Posttraumatic Stress Disorder (PTSD) and Cannabis Use Disorder (CUD). Every year, many women face the trauma of sexual assault, and a significant number of them may struggle with PTSD and turn to cannabis as a way to cope. The goal of this research is to see how well this digital therapy works and how acceptable it is for those who need it. The study aims to help the women who seek emergency care after an assault, providing them with a new way to prevent these serious issues.

To be eligible for this trial, participants must be women who have survived a sexual assault and sought emergency care within 72 hours of the event. They should be at least 18 years old, speak English, and own a smartphone that has been in service for over a year. Participants will need to report using cannabis more than once a week and show signs of anxiety. Throughout the trial, women will receive training and support while using the digital therapy. It's important to note that certain conditions, such as being currently pregnant or having serious cognitive issues, may exclude someone from participating. This trial represents an important step in finding new ways to support women in their recovery after such traumatic experiences.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Women sexual assault survivors presenting for emergency care \<72 hours post-assault at 1 of our 4 emergency care sites
  • 2. English speakers
  • 3. 18+ years of age
  • 4. Able to provide informed consent
  • 5. Have a smartphone with continuous service \>1 year
  • 6. Report \>1x/weekly cannabis use on a substance use screener
  • 7. Report elevated AS (\>17 on the Anxiety Sensitivity Index-3)
  • Exclusion Criteria:
  • 1. Inability to provide informed consent (e.g., serious injury preventing the ability to hear, speak, or see to consent and participate, or other causes (e.g., diagnosed cognitive deficits, diagnosed dementia, asleep at time of screening)).
  • 2. Prisoner
  • 3. Currently pregnant
  • 4. Lives with assailant and plans to continue to do so
  • 5. Admitted patient
  • 6. No mailing address
  • 7. Previously enrolled
  • 8. No sexual assault nurse examiner (SANE) examination
  • 9. Reporting current plan and intent for suicide or homicide
  • 10. Does not understand written and spoken English

About University Of Nevada, Las Vegas

The University of Nevada, Las Vegas (UNLV) is a prominent research institution committed to advancing healthcare through innovative clinical trials. With a focus on multidisciplinary collaboration, UNLV engages in rigorous scientific inquiry to explore new treatments and interventions that address pressing health challenges. The university's dedicated faculty and state-of-the-art facilities foster an environment conducive to cutting-edge research, ensuring the highest standards of ethical practice and patient care. Through its clinical trials, UNLV aims to contribute to the body of medical knowledge while improving health outcomes for diverse populations.

Locations

Chapel Hill, North Carolina, United States

Las Vegas, Nevada, United States

Tulsa, Oklahoma, United States

Austin, Texas, United States

Minneapolis, Minnesota, United States

Smithfield, North Carolina, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported